SAN DIEGO, Aug. 13 /PRNewswire-FirstCall/ — On June 22, 2009, Cetyl Max/Flexadren mischaracterized certain facts associated with the settlement between those entities and Imagenetix (OTC Bulletin Board: IAGX – News). Both companies extend their apologies to Imagenetix and to those who may have been affected by the mischaracterization.
Imagenetix (IAGX) Obtains Apology
Previous post: Boston University Periodontal Study on Imagenetix Compound Published in The Journal of Periodontology
Next post: Imagenetix Announces Interview with Bloomberg Radio
Comments on this entry are closed.